Issued to Mayo clinic for performance outcomes 1 and 2 from July 21 announcement? I assume these are: pilot trial completion and acceptance of proof of concept (1,186,153 shares); and FDA clearance of herabeat plus for home care (1,581,538 shares).
hopefully Mayo outcome 3, commercial launch, isn't to far away.
